
Join to view full profile
55 Fruit StBoston, MA 02114
Phone+1 413-739-9970
Dr. Gupta is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Raavi Gupta is a Brooklyn-based pathologist with subspecialties in hematopathology, anatomic pathology, and clinical pathology. She completed her medical education at King George's/CSM Medical College and pursued pathology residencies at UMass Chan - Baystate and NYU Grossman School of Medicine. Dr. Gupta also completed a hematopathology fellowship at NewYork-Presbyterian Hospital and a surgical pathology fellowship at NYU Langone School of Medicine. She recently earned her MBA from Columbia Business School, graduating with Dean's List honors. Her research has been published in noted journals such as PLOS ONE, Scientific Reports (Nature), Archives, International Journal of Gynecological Pathology, and JAMA Network Open, among others. She has led clinical trial to launch new miRNA based tests for prostate cancer and explore a new class of drugs for treatment of inflammatory conditions.
Education & Training
Columbia Business SchoolMBA, Deans List, 2022 - 2024
NYU Grossman School of MedicineResidency, Pathology-Anatomic and Clinical, 2007 - 2008
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematopathology, 2006 - 2007
UMass Chan - BaystateResidency, Pathology-Anatomic and Clinical, 2002 - 2006
King George's/CSM Medical CollegeClass of 1998
Certifications & Licensure
MA State Medical License 2006 - 2028
NY State Medical License 2008 - 2028
NJ State Medical License 2024 - 2027
VA State Medical License 2012 - 2026
CT State Medical License 2025 - 2025
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
American Board of Pathology Hematopathology
Clinical Trials
- Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19 Start of enrollment: 2021 Mar 11
Publications & Presentations
PubMed
- Stratifying Errors in Anthropic's Chatbot Claude-Simplified Pathology Reports.Eric Steimetz, Jeremy Minkowitz, Elmer C Gabutan, Joan Ngichabe, Hagar Attia
Archives of Pathology & Laboratory Medicine. 2025-12-01 - Excision of a rectal duplication cyst in proximity to the glomus coccygeum - An unusual cause of intraoperative bleeding: A case report.Varag Abed, Marla Sacks, Carlos Reck, Raavi Gupta, Harry Zinn
International Journal of Surgery Case Reports. 2025-10-01 - 1 citationsMolecular and Clinicopathologic Characterization of HER2-overexpressed Squamous Cell Carcinoma of the Cervix.Rachelle P Mendoza, Madhurya Ramineni, Kristina Doytcheva, Elmer C Gabutan, Raavi Gupta
International Journal of Gynecological Pathology. 2025-07-01
Journal Articles
- Case Report: Monoclonal Gammopathy of Undetermined Significance Is Associated with Loa Loa InfectionRaavi Gupta, Herbert B Tanowitz, Derek B Laskar, The American Journal of Tropical Medicine and Hygiene
Press Mentions
Histogen and Amerimmune Report Publication on Emricasan in COVID-19May 19th, 2021- Histogen and Amerimmune Announce First Patient Dosed in Phase 1 Study of Emricasan in Symptomatic COVID-19 PatientsMarch 16th, 2021
Grant Support
- Examination of markers of CDK4 inhibitory response in breast cancerNational Institute of Health2021–2026
- Novel complex structural variants and epigenetic alterations link the genomes of prostate cancer in African Americans with outcome disparityDepartment of Defense2021–2024
Committees
- Member from New York State, House of Delegates, College of American Pathologists 2016 - Present
Professional Memberships
- New York Pathological SocietyTreasurer and Past President
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









